Efficient therapy to treat hormone resistant tumorSelective inhibition of prostate cancer cellsProvides a specific drug target against an extremely difficult-to-treat cancerExtensive cancerous cell death upon administration
[更多]
PROTAC technology is emerging as a novel therapeutic method to target diseases caused by the abnormal expression of a disease-causing proteins. PROTACs simultaneously bind a target protein and its E3-ubiquitin ligase, causing ubiquitination and degradation of the target protein. Studying protein-pro.....
[更多]
The methods/compositions:ΓÇóEnable differentiation of stem/progenitor cells into oocytes and/or eggsΓÇóCan be applied both ex vivo or in vivo or as a combination to maximize desired outcomesΓÇóProvide a non-invasive procedure to increase oocyte numbers in the ovariesΓÇóAvoid use of potentially harmf.....
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
